Compare DCOMP & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DCOMP | MDAIW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 887 | 78 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | DCOMP | MDAIW |
|---|---|---|
| Price | $19.43 | $0.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 35.6K |
| Earning Date | N/A | 02-27-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,264,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 44.52 |
| 52 Week Low | N/A | $0.08 |
| 52 Week High | N/A | $0.90 |
| Indicator | DCOMP | MDAIW |
|---|---|---|
| Relative Strength Index (RSI) | 53.65 | 48.56 |
| Support Level | $19.07 | $0.43 |
| Resistance Level | $19.28 | $0.54 |
| Average True Range (ATR) | 0.22 | 0.07 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 45.00 | 22.97 |
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.